Primary Site >> Esophagus Cancer
Gene >> SLC2A1
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas. PMID: 11268453 |
Ref: Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. PMID: 11505409 |
Ref: Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness. PMID: 12529975 |
Ref: Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer. PMID: 15816463 Ref: Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis. PMID: 16045581 |
Ref: Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras. PMID: 17079462 |
Ref: [Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer]. PMID: 17575690 |
Ref: Correlations between selected tumor markers and fluorodeoxyglucose maximal standardized uptake values in esophageal cancer. PMID: 19136271 Ref: Adenomatoid tumor of the pleura. PMID: 19627540 |
Ref: Glucose transporter expression of an esophageal gastrointestinal tumor detected by F-18 FDG PET/CT. PMID: 20548142 |
Ref: Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy. PMID: 22870123 |
Ref: High expression of glucose transporter 1 on primary lesions of esophageal squamous cell carcinoma is associated with hematogenous recurrence. PMID: 24242681 Ref: Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer. PMID: 24939624 |
Ref: Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: A systematic review. PMID: 28705470 |
Ref: miR-143 Regulates Memory T Cell Differentiation by Reprogramming T Cell Metabolism. PMID: 30150287 |